Dr. Wei Zhu is currently the Chief Medical Officer of Inmagene Biopharmaceuticals. Her responsibilities include immunology pipeline establishment, medical development planning and clinical project operation.
Dr. Zhu graduated from Peking Union Medical College with 8 years of medical training with specialty in immunology and rheumatology and received a Ph.D. Dr. Zhu has 25 years of global clinical drug development experience at MNCs, including UCB, Novartis, Celgene, BMS and Schering-Plough, which focused on immunology and oncology.
Before joining Inmagene, Dr.Zhu has led global immunology pipeline establishment, managed global immunology TA team and developed the related strategies. As the head of clinical development, Dr. Zhu led 7 products through global registration and pipeline management with 20+ targets.